{"data":{"id":"us/21-cfr-1.1440","jurisdiction":"us","citation":"21 CFR 1.1440","heading":"What process will FDA follow when waiving a requirement of this subpart on our own initiative?","body":"(a) If FDA, on our own initiative, determines that a waiver of one or more requirements for an individual entity or type of entity is appropriate, we will publish a notice in the Federal Register setting forth the proposed waiver and the reasons for such waiver. The notice will establish a public docket so that interested persons may submit written comments on the proposal.\n(b) After considering any comments timely submitted, we will publish a notice in the Federal Register stating whether we are granting the waiver (in whole or in part) and the reasons for our decision.\n(c) Any waiver for a type of entity that FDA grants will become effective on the date that notice of the waiver is published in the Federal Register, unless otherwise stated in the notice.","path":["Title 21—Food and Drugs","CHAPTER I—FOOD AND DRUG ADMINISTRATION, DEPARTMENT OF HEALTH AND HUMAN SERVICES","SUBCHAPTER A—GENERAL","PART 1—GENERAL ENFORCEMENT REGULATIONS","Subpart S—Additional Traceability Records for Certain Foods"],"source_url":"https://www.ecfr.gov/api/versioner/v1/full/2026-08-25/title-21.xml","current_through":"2026-08-25","vintage":"","retrieved_at":"2026-08-27T02:24:47Z","sha256":"da26d1c73c803a56f1eee5a8a24302785b07326763d3c93e51fefe7d47a40b00","source_id":"us-cfr","stale":true,"prev":"us/21-cfr-1.1435","next":"us/21-cfr-1.1445"},"notice":"GroundRules: Original legal text. Not legal advice."}